id,creation_datetime,patientID,sample_id,HGNC,value,temporality,source
1,2024-07-10 11:35:12.177091,CS_BW-09109-0376,DS-vem-065-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2,2024-07-10 11:35:12.177091,CS_BW-09109-0376,DS-vem-065-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
4,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
5,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
6,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
7,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
8,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
9,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
10,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
11,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
12,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
13,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
14,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
15,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
16,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
17,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
18,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
19,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
20,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
21,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
22,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
23,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
24,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
25,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
26,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,MYC,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
27,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
28,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
29,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
30,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
31,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
32,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
33,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
34,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
35,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
36,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
37,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
38,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
39,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
40,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
41,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
42,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
43,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
44,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
45,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
46,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
47,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
48,2024-07-10 11:35:12.177326,CS_BW-09109-0376,DS-vem-065-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
49,2024-07-10 11:35:12.178092,CS_BW-09109-0376,DS-vem-065-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
50,2024-07-10 11:35:12.178092,CS_BW-09109-0376,DS-vem-065-T,NBN,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
51,2024-07-10 11:35:12.178092,CS_BW-09109-0376,DS-vem-065-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
52,2024-07-10 11:35:12.178092,CS_BW-09109-0376,DS-vem-065-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
53,2024-07-10 11:35:12.178092,CS_BW-09109-0376,DS-vem-065-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
54,2024-07-10 11:35:12.178092,CS_BW-09109-0376,DS-vem-065-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
55,2024-07-10 11:35:12.178092,CS_BW-09109-0376,DS-vem-065-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
56,2024-07-10 11:35:12.178092,CS_BW-09109-0376,DS-vem-065-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
57,2024-07-10 11:35:12.178092,CS_BW-09109-0376,DS-vem-065-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
58,2024-07-10 11:35:12.178092,CS_BW-09109-0376,DS-vem-065-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
59,2024-07-10 11:35:12.178092,CS_BW-09109-0376,DS-vem-065-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
60,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
61,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
62,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
63,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
64,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
65,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
66,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
67,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
68,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
69,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
70,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
71,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
72,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
73,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
74,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
75,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
76,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
77,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
78,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
79,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
80,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
81,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
82,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
83,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
84,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
85,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
86,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
87,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
88,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
89,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
90,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
91,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
92,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
93,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
94,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
95,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
96,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
97,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
98,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
99,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
100,2024-07-10 11:35:12.178092,CS_JJ-1446,DS-vem-066-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
101,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
102,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
103,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
104,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
105,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
106,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
107,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
108,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
109,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
110,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
111,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
112,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
113,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
114,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
115,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
116,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
117,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
118,2024-07-10 11:35:12.184281,CS_JJ-1446,DS-vem-066-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
119,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
120,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
121,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
122,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
123,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
124,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,CDKN2B,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
125,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
126,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
127,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
128,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
129,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,CDKN2A,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
130,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
131,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
132,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
133,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
134,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
135,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
136,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
137,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
138,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
139,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
140,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
141,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
142,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
143,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
144,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
145,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
146,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
147,2024-07-10 11:35:12.184281,CS_MF-1517,DS-vem-067-T,IGF1R,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
148,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
149,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
150,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
151,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
152,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
153,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
154,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
155,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
156,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
157,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
158,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
159,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
160,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
161,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
162,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
163,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
164,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
165,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
166,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
167,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
168,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
169,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
170,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
171,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
172,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
173,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
174,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
175,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
176,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
177,2024-07-10 11:35:12.185271,CS_MF-1517,DS-vem-067-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
178,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
179,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
180,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
181,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
182,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
183,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
184,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
185,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
186,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
187,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
188,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
189,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
190,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
191,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
192,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
193,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
194,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
195,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
196,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
197,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
198,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
199,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
200,2024-07-10 11:35:12.185271,CS_NF-1117,DS-vem-068-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
201,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
202,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
203,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
204,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
205,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
206,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
207,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
208,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
209,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
210,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
211,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
212,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
213,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
214,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
215,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
216,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
217,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
218,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
219,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
220,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
221,2024-07-10 11:35:12.188273,CS_NF-1117,DS-vem-068-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
222,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
223,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
224,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
225,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
226,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
227,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
228,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
229,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
230,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
231,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
232,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
233,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
234,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
235,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
236,2024-07-10 11:35:12.189271,CS_NF-1117,DS-vem-068-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
237,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
238,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
239,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
240,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
241,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
242,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
243,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
244,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
245,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
246,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
247,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
248,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
249,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
250,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
251,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
252,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
253,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
254,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
255,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
256,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
257,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
258,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
259,2024-07-10 11:35:12.189271,CS_LL-0757,DS-vem-069-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
260,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
261,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
262,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
263,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
264,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
265,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
266,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
267,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
268,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
269,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
270,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
271,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
272,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
273,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
274,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
275,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
276,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
277,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
278,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
279,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
280,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
281,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
282,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
283,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
284,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
285,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
286,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
287,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
288,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
289,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
290,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
291,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
292,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
293,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
294,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
295,2024-07-10 11:35:12.190271,CS_LL-0757,DS-vem-069-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
296,2024-07-10 11:35:12.190271,CS_SF-1262,DS-vem-070-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
297,2024-07-10 11:35:12.190271,CS_SF-1262,DS-vem-070-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
298,2024-07-10 11:35:12.190271,CS_SF-1262,DS-vem-070-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
299,2024-07-10 11:35:12.190271,CS_SF-1262,DS-vem-070-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
300,2024-07-10 11:35:12.190271,CS_SF-1262,DS-vem-070-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
301,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
302,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
303,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
304,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
305,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
306,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
307,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
308,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
309,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
310,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
311,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
312,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
313,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
314,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
315,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
316,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
317,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
318,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
319,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
320,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
321,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
322,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
323,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
324,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
325,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
326,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
327,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
328,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
329,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
330,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
331,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
332,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
333,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
334,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
335,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
336,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
337,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
338,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
339,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
340,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
341,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
342,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
343,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
344,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
345,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
346,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
347,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
348,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,INSR,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
349,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
350,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
351,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
352,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
353,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
354,2024-07-10 11:35:12.192756,CS_SF-1262,DS-vem-070-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
355,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
356,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
357,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
358,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
359,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
360,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
361,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
362,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
363,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
364,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
365,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
366,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
367,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
368,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
369,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
370,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
371,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,MET,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
372,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
373,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,EZH2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
374,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,MLL3,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
375,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
376,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
377,2024-07-10 11:35:12.192756,CS_EC-0470,DS-vem-071-T,BRAF,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
378,2024-07-10 11:35:12.194302,CS_EC-0470,DS-vem-071-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
379,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,DAXX,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
380,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
381,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
382,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
383,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
384,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
385,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
386,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
387,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
388,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
389,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
390,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
391,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
392,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
393,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
394,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
395,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
396,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
397,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
398,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
399,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
400,2024-07-10 11:35:12.194307,CS_EC-0470,DS-vem-071-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
401,2024-07-10 11:35:12.198171,CS_EC-0470,DS-vem-071-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
402,2024-07-10 11:35:12.198171,CS_EC-0470,DS-vem-071-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
403,2024-07-10 11:35:12.198171,CS_EC-0470,DS-vem-071-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
404,2024-07-10 11:35:12.198171,CS_EC-0470,DS-vem-071-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
405,2024-07-10 11:35:12.198171,CS_EC-0470,DS-vem-071-T,IRF4,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
406,2024-07-10 11:35:12.198171,CS_EC-0470,DS-vem-071-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
407,2024-07-10 11:35:12.198171,CS_EC-0470,DS-vem-071-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
408,2024-07-10 11:35:12.198171,CS_EC-0470,DS-vem-071-T,FH,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
409,2024-07-10 11:35:12.198171,CS_EC-0470,DS-vem-071-T,PRKAR1A,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
410,2024-07-10 11:35:12.198171,CS_EC-0470,DS-vem-071-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
411,2024-07-10 11:35:12.198171,CS_EC-0470,DS-vem-071-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
412,2024-07-10 11:35:12.198171,CS_EC-0470,DS-vem-071-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
413,2024-07-10 11:35:12.198171,CS_EC-0470,DS-vem-071-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
414,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
415,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
416,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
417,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
418,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
419,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
420,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
421,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
422,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
423,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
424,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
425,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
426,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
427,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
428,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
429,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
430,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
431,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
432,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
433,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
434,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
435,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
436,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
437,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
438,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,DAXX,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
439,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
440,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
441,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,MITF,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
442,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
443,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
444,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
445,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
446,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
447,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
448,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
449,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
450,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
451,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
452,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
453,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
454,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
455,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
456,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
457,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
458,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
459,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
460,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
461,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
462,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
463,2024-07-10 11:35:12.198171,CS_TW0880,DS-vem-072-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
464,2024-07-10 11:35:12.199170,CS_TW0880,DS-vem-072-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
465,2024-07-10 11:35:12.199170,CS_TW0880,DS-vem-072-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
466,2024-07-10 11:35:12.199170,CS_TW0880,DS-vem-072-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
467,2024-07-10 11:35:12.199170,CS_TW0880,DS-vem-072-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
468,2024-07-10 11:35:12.199170,CS_TW0880,DS-vem-072-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
469,2024-07-10 11:35:12.199170,CS_TW0880,DS-vem-072-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
470,2024-07-10 11:35:12.199170,CS_TW0880,DS-vem-072-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
471,2024-07-10 11:35:12.199170,CS_TW0880,DS-vem-072-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
472,2024-07-10 11:35:12.199170,CS_TW0880,DS-vem-072-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
473,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
474,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,MDM2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
475,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
476,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
477,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,PTEN,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
478,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
479,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
480,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
481,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
482,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
483,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
484,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
485,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
486,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
487,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
488,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
489,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
490,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
491,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
492,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
493,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
494,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
495,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
496,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
497,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
498,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
499,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
500,2024-07-10 11:35:12.199170,CS_JM-1218,DS-vem-073-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
501,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
502,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
503,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
504,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
505,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
506,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
507,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
508,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
509,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
510,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
511,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
512,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
513,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
514,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
515,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
516,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
517,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
518,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
519,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
520,2024-07-10 11:35:12.202172,CS_JM-1218,DS-vem-073-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
521,2024-07-10 11:35:12.203170,CS_JM-1218,DS-vem-073-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
522,2024-07-10 11:35:12.203170,CS_JM-1218,DS-vem-073-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
523,2024-07-10 11:35:12.203170,CS_JM-1218,DS-vem-073-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
524,2024-07-10 11:35:12.203170,CS_JM-1218,DS-vem-073-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
525,2024-07-10 11:35:12.203170,CS_JM-1218,DS-vem-073-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
526,2024-07-10 11:35:12.203170,CS_JM-1218,DS-vem-073-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
527,2024-07-10 11:35:12.203170,CS_JM-1218,DS-vem-073-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
528,2024-07-10 11:35:12.203170,CS_JM-1218,DS-vem-073-T,CCND1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
529,2024-07-10 11:35:12.203170,CS_JM-1218,DS-vem-073-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
530,2024-07-10 11:35:12.203170,CS_JM-1218,DS-vem-073-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
531,2024-07-10 11:35:12.203170,CS_JM-1218,DS-vem-073-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
532,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
533,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
534,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
535,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
536,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
537,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
538,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
539,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
540,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
541,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
542,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
543,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
544,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
545,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
546,2024-07-10 11:35:12.203170,CS_SB-0663,DS-vem-074-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
547,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
548,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
549,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
550,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
551,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
552,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
553,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
554,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
555,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
556,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
557,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
558,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
559,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,MITF,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
560,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
561,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
562,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
563,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
564,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
565,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
566,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
567,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
568,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
569,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
570,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
571,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
572,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
573,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
574,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
575,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
576,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
577,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
578,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
579,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
580,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
581,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
582,2024-07-10 11:35:12.203559,CS_SB-0663,DS-vem-074-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
583,2024-07-10 11:35:12.204170,CS_SB-0663,DS-vem-074-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
584,2024-07-10 11:35:12.204170,CS_SB-0663,DS-vem-074-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
585,2024-07-10 11:35:12.204170,CS_SB-0663,DS-vem-074-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
586,2024-07-10 11:35:12.204170,CS_SB-0663,DS-vem-074-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
587,2024-07-10 11:35:12.204170,CS_SB-0663,DS-vem-074-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
588,2024-07-10 11:35:12.204170,CS_SB-0663,DS-vem-074-T,SHQ1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
589,2024-07-10 11:35:12.204170,CS_SB-0663,DS-vem-074-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
590,2024-07-10 11:35:12.204170,CS_SB-0663,DS-vem-074-T,APC,-1,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
591,2024-07-10 11:35:12.204170,CS_RB-0857,DS-vem-075-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
592,2024-07-10 11:35:12.204170,CS_RB-0857,DS-vem-075-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
593,2024-07-10 11:35:12.204170,CS_RB-0857,DS-vem-075-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
594,2024-07-10 11:35:12.204170,CS_RB-0857,DS-vem-075-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
595,2024-07-10 11:35:12.204170,CS_RB-0857,DS-vem-075-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
596,2024-07-10 11:35:12.204170,CS_RB-0857,DS-vem-075-T,CDKN2B,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
597,2024-07-10 11:35:12.204170,CS_RB-0857,DS-vem-075-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
598,2024-07-10 11:35:12.204170,CS_RB-0857,DS-vem-075-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
599,2024-07-10 11:35:12.204170,CS_RB-0857,DS-vem-075-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
600,2024-07-10 11:35:12.204170,CS_RB-0857,DS-vem-075-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
601,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,CDKN2A,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
602,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
603,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
604,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
605,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
606,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
607,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
608,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
609,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
610,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
611,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
612,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
613,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
614,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
615,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
616,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
617,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
618,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
619,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
620,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,ETV1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
621,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
622,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
623,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
624,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
625,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
626,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
627,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,PARK2,-1,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
628,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
629,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
630,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
631,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
632,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
633,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
634,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
635,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
636,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
637,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
638,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
639,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
640,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
641,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,IRF4,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
642,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
643,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
644,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
645,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
646,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
647,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
648,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,CDC42EP2,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
649,2024-07-10 11:35:12.207207,CS_RB-0857,DS-vem-075-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
650,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
651,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
652,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
653,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
654,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,PTEN,-1,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
655,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
656,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
657,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
658,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
659,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
660,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
661,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
662,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
663,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
664,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
665,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
666,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
667,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
668,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
669,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
670,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
671,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
672,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
673,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
674,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
675,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
676,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
677,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
678,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
679,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
680,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
681,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
682,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
683,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
684,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
685,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
686,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
687,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
688,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
689,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
690,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
691,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
692,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
693,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
694,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
695,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
696,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
697,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
698,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
699,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
700,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
701,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
702,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
703,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
704,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
705,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
706,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
707,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
708,2024-07-10 11:35:12.207207,CS_JS-0953,DS-vem-076-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
709,2024-07-10 11:35:12.212895,CS_DB-1159,DS-vem-077-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
710,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
711,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
712,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
713,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,PTEN,-1,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
714,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
715,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
716,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
717,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
718,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
719,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
720,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
721,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
722,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
723,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
724,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
725,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
726,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
727,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
728,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
729,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
730,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
731,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
732,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
733,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
734,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
735,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
736,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
737,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
738,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
739,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
740,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
741,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
742,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,ERBB3,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
743,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
744,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,CDK4,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
745,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
746,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
747,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
748,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
749,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
750,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
751,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
752,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
753,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
754,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
755,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
756,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
757,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
758,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
759,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
760,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
761,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
762,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
763,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
764,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
765,2024-07-10 11:35:12.212911,CS_DB-1159,DS-vem-077-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
766,2024-07-10 11:35:12.213896,CS_DB-1159,DS-vem-077-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
767,2024-07-10 11:35:12.213896,CS_DB-1159,DS-vem-077-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
768,2024-07-10 11:35:12.213896,CS_DT-1153,DS-vem-079-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
769,2024-07-10 11:35:12.213896,CS_DT-1153,DS-vem-079-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
770,2024-07-10 11:35:12.213896,CS_DT-1153,DS-vem-079-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
771,2024-07-10 11:35:12.213896,CS_DT-1153,DS-vem-079-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
772,2024-07-10 11:35:12.213896,CS_DT-1153,DS-vem-079-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
773,2024-07-10 11:35:12.213896,CS_DT-1153,DS-vem-079-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
774,2024-07-10 11:35:12.213896,CS_DT-1153,DS-vem-079-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
775,2024-07-10 11:35:12.213896,CS_DT-1153,DS-vem-079-T,MCL1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
776,2024-07-10 11:35:12.213896,CS_DT-1153,DS-vem-079-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
777,2024-07-10 11:35:12.213896,CS_DT-1153,DS-vem-079-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
778,2024-07-10 11:35:12.213896,CS_DT-1153,DS-vem-079-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
779,2024-07-10 11:35:12.213896,CS_DT-1153,DS-vem-079-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
780,2024-07-10 11:35:12.214176,CS_DT-1153,DS-vem-079-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
781,2024-07-10 11:35:12.214176,CS_DT-1153,DS-vem-079-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
782,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
783,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
784,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
785,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
786,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
787,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
788,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
789,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
790,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
791,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
792,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
793,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
794,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
795,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
796,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
797,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
798,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
799,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
800,2024-07-10 11:35:12.214212,CS_DT-1153,DS-vem-079-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
801,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
802,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
803,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
804,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
805,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
806,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
807,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
808,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
809,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
810,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
811,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
812,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
813,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
814,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
815,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
816,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
817,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
818,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
819,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
820,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
821,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
822,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
823,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
824,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
825,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
826,2024-07-10 11:35:12.216222,CS_DT-1153,DS-vem-079-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
827,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
828,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
829,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
830,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
831,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
832,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
833,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
834,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
835,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
836,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
837,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
838,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
839,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
840,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
841,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
842,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
843,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
844,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
845,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
846,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
847,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
848,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
849,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
850,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
851,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
852,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
853,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
854,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
855,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
856,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
857,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
858,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
859,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
860,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
861,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
862,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
863,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
864,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
865,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
866,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
867,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
868,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
869,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
870,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
871,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
872,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
873,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
874,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
875,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
876,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
877,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
878,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
879,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
880,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
881,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
882,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
883,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
884,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
885,2024-07-10 11:35:12.216222,CS_DO-1227,DS-vem-081-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
886,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
887,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
888,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
889,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
890,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
891,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
892,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
893,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
894,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
895,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
896,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
897,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
898,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
899,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
900,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
901,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
902,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
903,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
904,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
905,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
906,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
907,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
908,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
909,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
910,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
911,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
912,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
913,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
914,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
915,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
916,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
917,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
918,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
919,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
920,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
921,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
922,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
923,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
924,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
925,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
926,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
927,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
928,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
929,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
930,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
931,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
932,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
933,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
934,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
935,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
936,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
937,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
938,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
939,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
940,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
941,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
942,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
943,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
944,2024-07-10 11:35:12.216222,CS_JP-1351,DS-vem-082-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
945,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
946,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
947,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
948,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
949,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
950,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
951,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
952,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
953,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
954,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
955,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
956,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
957,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
958,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
959,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
960,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
961,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
962,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
963,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
964,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
965,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
966,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
967,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
968,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
969,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
970,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
971,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
972,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
973,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
974,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
975,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
976,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
977,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
978,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
979,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
980,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
981,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
982,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
983,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
984,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
985,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
986,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
987,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
988,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
989,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
990,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
991,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
992,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
993,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
994,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
995,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
996,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
997,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
998,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
999,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1000,2024-07-10 11:35:12.216222,CS_CT-0923,DS-vem-083-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1001,2024-07-10 11:35:12.226439,CS_CT-0923,DS-vem-083-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1002,2024-07-10 11:35:12.226439,CS_CT-0923,DS-vem-083-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1003,2024-07-10 11:35:12.226439,CS_CT-0923,DS-vem-083-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1004,2024-07-10 11:35:12.226439,CS_HS-0929,DS-vem-084-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1005,2024-07-10 11:35:12.226439,CS_HS-0929,DS-vem-084-T,MDM2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1006,2024-07-10 11:35:12.226439,CS_HS-0929,DS-vem-084-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1007,2024-07-10 11:35:12.226439,CS_HS-0929,DS-vem-084-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1008,2024-07-10 11:35:12.226439,CS_HS-0929,DS-vem-084-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1009,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1010,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1011,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1012,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1013,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1014,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1015,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1016,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1017,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1018,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1019,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1020,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1021,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1022,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1023,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1024,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1025,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1026,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1027,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1028,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1029,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1030,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1031,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1032,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1033,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1034,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1035,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1036,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,HMGA2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1037,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1038,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1039,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1040,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1041,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1042,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1043,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1044,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1045,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1046,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1047,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1048,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1049,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1050,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1051,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1052,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1053,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1054,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1055,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1056,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1057,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1058,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1059,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1060,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1061,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1062,2024-07-10 11:35:12.227468,CS_HS-0929,DS-vem-084-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1063,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1064,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1065,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1066,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1067,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,PTEN,-1,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1068,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1069,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1070,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1071,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1072,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1073,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1074,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1075,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1076,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1077,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1078,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1079,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1080,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1081,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1082,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1083,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1084,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1085,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1086,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1087,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1088,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1089,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1090,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1091,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1092,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1093,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1094,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1095,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1096,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1097,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1098,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1099,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1100,2024-07-10 11:35:12.227468,CS_JL-1415,DS-vem-085-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1101,2024-07-10 11:35:12.231142,CS_JL-1415,DS-vem-085-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1102,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1103,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1104,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1105,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1106,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1107,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1108,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1109,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1110,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1111,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1112,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1113,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1114,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1115,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1116,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1117,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1118,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1119,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1120,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1121,2024-07-10 11:35:12.232139,CS_JL-1415,DS-vem-085-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1122,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1123,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1124,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1125,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1126,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1127,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1128,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1129,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1130,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1131,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1132,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1133,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1134,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1135,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1136,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1137,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1138,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1139,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1140,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1141,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1142,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1143,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1144,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1145,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1146,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1147,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1148,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1149,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1150,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1151,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1152,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1153,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1154,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1155,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1156,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1157,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1158,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1159,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1160,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1161,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1162,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1163,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1164,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1165,2024-07-10 11:35:12.232139,CS_SH-0183,DS-vem-086-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1166,2024-07-10 11:35:12.233141,CS_SH-0183,DS-vem-086-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1167,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1168,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1169,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1170,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1171,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1172,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1173,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1174,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1175,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1176,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1177,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1178,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1179,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1180,2024-07-10 11:35:12.233150,CS_SH-0183,DS-vem-086-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1181,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1182,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1183,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1184,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1185,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,PTEN,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1186,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,CDKN2B,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1187,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1188,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1189,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1190,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1191,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,CDKN2A,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1192,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1193,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,TEK,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1194,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1195,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1196,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1197,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1198,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1199,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1200,2024-07-10 11:35:12.233150,CS_GS-1127,DS-vem-087-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1201,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1202,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1203,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1204,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1205,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1206,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1207,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1208,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1209,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1210,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1211,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1212,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1213,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1214,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1215,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1216,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1217,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,PARK2,-1,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1218,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1219,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1220,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1221,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1222,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1223,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1224,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1225,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1226,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1227,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1228,2024-07-10 11:35:12.236195,CS_GS-1127,DS-vem-087-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1229,2024-07-10 11:35:12.237227,CS_GS-1127,DS-vem-087-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1230,2024-07-10 11:35:12.237227,CS_GS-1127,DS-vem-087-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1231,2024-07-10 11:35:12.237227,CS_GS-1127,DS-vem-087-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1232,2024-07-10 11:35:12.237227,CS_GS-1127,DS-vem-087-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1233,2024-07-10 11:35:12.237227,CS_GS-1127,DS-vem-087-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1234,2024-07-10 11:35:12.237227,CS_GS-1127,DS-vem-087-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1235,2024-07-10 11:35:12.237227,CS_GS-1127,DS-vem-087-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1236,2024-07-10 11:35:12.237227,CS_GS-1127,DS-vem-087-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1237,2024-07-10 11:35:12.237227,CS_GS-1127,DS-vem-087-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1238,2024-07-10 11:35:12.237227,CS_GS-1127,DS-vem-087-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1239,2024-07-10 11:35:12.237227,CS_GS-1127,DS-vem-087-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1240,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1241,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1242,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1243,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1244,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1245,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1246,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1247,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,MCL1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1248,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1249,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1250,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1251,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1252,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1253,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1254,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1255,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1256,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1257,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1258,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1259,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1260,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1261,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1262,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1263,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1264,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,DAXX,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1265,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1266,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1267,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1268,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1269,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1270,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1271,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1272,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1273,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1274,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1275,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1276,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1277,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1278,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1279,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1280,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1281,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1282,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1283,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1284,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1285,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1286,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1287,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1288,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1289,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1290,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1291,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1292,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1293,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1294,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1295,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1296,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1297,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1298,2024-07-10 11:35:12.237227,CS_FF-1202,DS-vem-088-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1299,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1300,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1301,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1302,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1303,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1304,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1305,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,CDKN2C,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1306,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1307,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1308,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1309,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1310,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1311,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1312,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1313,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1314,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1315,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1316,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1317,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1318,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1319,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1320,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1321,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1322,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1323,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1324,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1325,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1326,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1327,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1328,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1329,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1330,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1331,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1332,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1333,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1334,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1335,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1336,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1337,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1338,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1339,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1340,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1341,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1342,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1343,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1344,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1345,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1346,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1347,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1348,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1349,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1350,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1351,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1352,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1353,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1354,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1355,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1356,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1357,2024-07-10 11:35:12.237227,CS_JH-1397,DS-vem-089-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1358,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1359,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1360,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1361,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1362,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1363,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1364,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1365,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1366,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1367,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1368,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1369,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1370,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1371,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1372,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1373,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1374,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1375,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1376,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1377,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1378,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1379,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1380,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1381,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1382,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1383,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1384,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1385,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1386,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1387,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1388,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1389,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1390,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1391,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1392,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1393,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1394,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1395,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1396,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1397,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1398,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1399,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1400,2024-07-10 11:35:12.237227,CS_MS-1386,DS-vem-090-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1401,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1402,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1403,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1404,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1405,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1406,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1407,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1408,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1409,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1410,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1411,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1412,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1413,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1414,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1415,2024-07-10 11:35:12.246277,CS_MS-1386,DS-vem-090-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1416,2024-07-10 11:35:12.246741,CS_MS-1386,DS-vem-090-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1417,2024-07-10 11:35:12.246741,CS_MS-2,DS-vem-092-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1418,2024-07-10 11:35:12.246741,CS_MS-2,DS-vem-092-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1419,2024-07-10 11:35:12.246741,CS_MS-2,DS-vem-092-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1420,2024-07-10 11:35:12.246741,CS_MS-2,DS-vem-092-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1421,2024-07-10 11:35:12.246741,CS_MS-2,DS-vem-092-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1422,2024-07-10 11:35:12.246741,CS_MS-2,DS-vem-092-T,CDKN2B,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1423,2024-07-10 11:35:12.246741,CS_MS-2,DS-vem-092-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1424,2024-07-10 11:35:12.246741,CS_MS-2,DS-vem-092-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1425,2024-07-10 11:35:12.246741,CS_MS-2,DS-vem-092-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1426,2024-07-10 11:35:12.246741,CS_MS-2,DS-vem-092-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1427,2024-07-10 11:35:12.246741,CS_MS-2,DS-vem-092-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1428,2024-07-10 11:35:12.246741,CS_MS-2,DS-vem-092-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1429,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1430,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1431,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1432,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1433,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1434,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1435,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1436,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1437,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1438,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1439,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1440,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1441,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1442,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1443,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1444,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1445,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1446,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1447,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1448,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1449,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1450,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1451,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1452,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1453,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1454,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1455,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1456,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1457,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1458,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1459,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1460,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1461,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1462,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1463,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1464,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1465,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1466,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1467,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1468,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1469,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1470,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1471,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1472,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1473,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1474,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1475,2024-07-10 11:35:12.246935,CS_MS-2,DS-vem-092-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1476,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1477,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1478,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1479,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1480,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1481,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1482,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1483,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1484,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1485,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1486,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1487,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1488,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1489,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1490,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1491,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1492,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1493,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1494,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1495,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1496,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1497,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1498,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1499,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1500,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1501,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1502,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1503,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1504,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1505,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1506,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1507,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1508,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1509,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1510,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1511,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1512,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1513,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1514,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1515,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1516,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1517,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1518,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1519,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1520,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1521,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1522,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1523,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1524,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1525,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1526,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1527,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1528,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1529,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1530,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1531,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1532,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1533,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1534,2024-07-10 11:35:12.246935,CS_VT002p,DS-vem-02-PT1,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1535,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1536,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1537,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1538,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1539,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1540,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1541,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1542,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1543,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1544,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1545,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1546,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1547,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1548,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1549,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1550,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1551,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1552,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1553,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1554,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1555,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1556,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1557,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1558,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1559,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1560,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1561,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1562,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1563,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1564,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1565,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1566,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1567,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1568,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1569,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1570,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1571,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1572,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1573,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1574,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1575,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1576,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1577,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1578,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1579,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1580,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1581,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1582,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1583,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1584,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1585,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1586,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1587,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1588,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1589,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1590,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1591,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1592,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1593,2024-07-10 11:35:12.246935,CS_VT010,DS-vem-10-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1594,2024-07-10 11:35:12.246935,CS_VT011,DS-vem-11-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1595,2024-07-10 11:35:12.246935,CS_VT011,DS-vem-11-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1596,2024-07-10 11:35:12.246935,CS_VT011,DS-vem-11-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1597,2024-07-10 11:35:12.246935,CS_VT011,DS-vem-11-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1598,2024-07-10 11:35:12.246935,CS_VT011,DS-vem-11-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1599,2024-07-10 11:35:12.246935,CS_VT011,DS-vem-11-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1600,2024-07-10 11:35:12.246935,CS_VT011,DS-vem-11-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1601,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1602,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1603,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1604,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1605,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1606,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1607,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1608,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1609,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1610,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1611,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1612,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1613,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1614,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1615,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1616,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1617,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1618,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1619,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1620,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1621,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1622,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1623,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1624,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1625,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1626,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1627,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1628,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1629,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1630,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1631,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1632,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1633,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1634,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1635,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1636,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1637,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1638,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1639,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1640,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1641,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1642,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1643,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1644,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1645,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1646,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1647,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1648,2024-07-10 11:35:12.256486,CS_VT011,DS-vem-11-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1649,2024-07-10 11:35:12.257523,CS_VT011,DS-vem-11-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1650,2024-07-10 11:35:12.257523,CS_VT011,DS-vem-11-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1651,2024-07-10 11:35:12.257523,CS_VT011,DS-vem-11-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1652,2024-07-10 11:35:12.257523,CS_VT011,DS-vem-11-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1653,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,PIK3CB,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1654,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,MDM2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1655,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,FOXL2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1656,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,PIK3CA,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1657,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,PTEN,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1658,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1659,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1660,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1661,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1662,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1663,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1664,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1665,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1666,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1667,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1668,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1669,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1670,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1671,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1672,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1673,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1674,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1675,2024-07-10 11:35:12.257523,CS_VT012,DS-vem-12-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1676,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1677,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1678,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1679,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1680,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1681,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1682,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1683,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1684,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1685,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1686,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1687,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1688,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1689,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1690,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1691,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1692,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1693,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1694,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1695,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1696,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1697,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1698,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1699,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1700,2024-07-10 11:35:12.257969,CS_VT012,DS-vem-12-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1701,2024-07-10 11:35:12.259006,CS_VT012,DS-vem-12-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1702,2024-07-10 11:35:12.259006,CS_VT012,DS-vem-12-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1703,2024-07-10 11:35:12.259006,CS_VT012,DS-vem-12-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1704,2024-07-10 11:35:12.259006,CS_VT012,DS-vem-12-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1705,2024-07-10 11:35:12.259006,CS_VT012,DS-vem-12-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1706,2024-07-10 11:35:12.259006,CS_VT012,DS-vem-12-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1707,2024-07-10 11:35:12.259006,CS_VT012,DS-vem-12-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1708,2024-07-10 11:35:12.259006,CS_VT012,DS-vem-12-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1709,2024-07-10 11:35:12.259006,CS_VT012,DS-vem-12-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1710,2024-07-10 11:35:12.259006,CS_VT012,DS-vem-12-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1711,2024-07-10 11:35:12.259006,CS_VT012,DS-vem-12-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1712,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1713,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1714,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1715,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1716,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1717,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,CDKN2B,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1718,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1719,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1720,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1721,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1722,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1723,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1724,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1725,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1726,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1727,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1728,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1729,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1730,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1731,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1732,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1733,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1734,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1735,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1736,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1737,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1738,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1739,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1740,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1741,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1742,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1743,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1744,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1745,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1746,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1747,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1748,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1749,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1750,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1751,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1752,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1753,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1754,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1755,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1756,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1757,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1758,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1759,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1760,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1761,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1762,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1763,2024-07-10 11:35:12.259006,CS_VT014,DS-vem-014-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1764,2024-07-10 11:35:12.262983,CS_VT014,DS-vem-014-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1765,2024-07-10 11:35:12.262999,CS_VT014,DS-vem-014-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1766,2024-07-10 11:35:12.262999,CS_VT014,DS-vem-014-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1767,2024-07-10 11:35:12.262999,CS_VT014,DS-vem-014-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1768,2024-07-10 11:35:12.262999,CS_VT014,DS-vem-014-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1769,2024-07-10 11:35:12.262999,CS_VT014,DS-vem-014-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1770,2024-07-10 11:35:12.262999,CS_VT014,DS-vem-014-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1771,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1772,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1773,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1774,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1775,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1776,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1777,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1778,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1779,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1780,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1781,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1782,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1783,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1784,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1785,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1786,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1787,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1788,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1789,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1790,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1791,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1792,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1793,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1794,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1795,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1796,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1797,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1798,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1799,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1800,2024-07-10 11:35:12.262999,CS_VT003p,DS-vem-03-PT,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1801,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1802,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1803,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1804,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1805,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1806,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1807,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1808,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1809,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1810,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1811,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1812,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1813,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1814,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1815,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1816,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1817,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1818,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1819,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1820,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1821,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1822,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1823,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1824,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1825,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1826,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1827,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1828,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1829,2024-07-10 11:35:12.266380,CS_VT003p,DS-vem-03-PT,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1830,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1831,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1832,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1833,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1834,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1835,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1836,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1837,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1838,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1839,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1840,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1841,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1842,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1843,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1844,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1845,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1846,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1847,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1848,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1849,2024-07-10 11:35:12.266380,CS_VT007m1,DS-vem-07-MT1,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1850,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1851,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1852,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1853,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1854,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1855,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1856,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1857,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1858,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1859,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1860,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1861,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1862,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1863,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1864,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1865,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1866,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1867,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1868,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1869,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1870,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1871,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1872,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1873,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1874,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1875,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1876,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1877,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1878,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1879,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1880,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1881,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1882,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1883,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1884,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1885,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1886,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1887,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1888,2024-07-10 11:35:12.267414,CS_VT007m1,DS-vem-07-MT1,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1889,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1890,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1891,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1892,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1893,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1894,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1895,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,CDKN2C,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1896,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,MCL1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1897,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,FGFR2,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1898,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,PTPRD,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1899,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,CDKN2A,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1900,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1901,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1902,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1903,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1904,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1905,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1906,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1907,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1908,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1909,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1910,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1911,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1912,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1913,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1914,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1915,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1916,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1917,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1918,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1919,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1920,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1921,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1922,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1923,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1924,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1925,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1926,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1927,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1928,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1929,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1930,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1931,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1932,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1933,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1934,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1935,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1936,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1937,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1938,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1939,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1940,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1941,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1942,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1943,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1944,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1945,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1946,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1947,2024-07-10 11:35:12.267414,CS_VT013m3,DS-vem-13-MT3,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1948,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1949,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1950,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1951,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1952,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,PTEN,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1953,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,CDKN2B,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1954,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1955,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1956,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,FGFR2,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1957,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1958,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,CDKN2A,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1959,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,FAS,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1960,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,TEK,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1961,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,MAP3K8,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1962,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,CHEK2,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1963,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,TET1,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1964,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1965,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1966,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1967,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1968,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1969,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1970,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1971,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1972,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1973,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1974,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1975,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1976,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1977,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1978,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1979,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1980,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1981,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1982,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1983,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1984,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1985,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1986,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1987,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1988,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1989,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1990,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1991,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1992,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1993,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1994,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1995,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1996,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1997,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1998,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
1999,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2000,2024-07-10 11:35:12.267414,CS_VT016m1,DS-vem-16-MT1,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2001,2024-07-10 11:35:12.275725,CS_VT016m1,DS-vem-16-MT1,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2002,2024-07-10 11:35:12.275725,CS_VT016m1,DS-vem-16-MT1,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2003,2024-07-10 11:35:12.275725,CS_VT016m1,DS-vem-16-MT1,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2004,2024-07-10 11:35:12.275725,CS_VT016m1,DS-vem-16-MT1,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2005,2024-07-10 11:35:12.275725,CS_VT016m1,DS-vem-16-MT1,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2006,2024-07-10 11:35:12.275725,CS_VT016m1,DS-vem-16-MT1,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2007,2024-07-10 11:35:12.275725,CS_VT019,DS-vem-019-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2008,2024-07-10 11:35:12.275725,CS_VT019,DS-vem-019-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2009,2024-07-10 11:35:12.275725,CS_VT019,DS-vem-019-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2010,2024-07-10 11:35:12.275725,CS_VT019,DS-vem-019-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2011,2024-07-10 11:35:12.275725,CS_VT019,DS-vem-019-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2012,2024-07-10 11:35:12.275725,CS_VT019,DS-vem-019-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2013,2024-07-10 11:35:12.275725,CS_VT019,DS-vem-019-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2014,2024-07-10 11:35:12.275725,CS_VT019,DS-vem-019-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2015,2024-07-10 11:35:12.275725,CS_VT019,DS-vem-019-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2016,2024-07-10 11:35:12.275725,CS_VT019,DS-vem-019-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2017,2024-07-10 11:35:12.275725,CS_VT019,DS-vem-019-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2018,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2019,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2020,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2021,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2022,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2023,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2024,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2025,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2026,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2027,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2028,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2029,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2030,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2031,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2032,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2033,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2034,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2035,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2036,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2037,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2038,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2039,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2040,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2041,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2042,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2043,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2044,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2045,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2046,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2047,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2048,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2049,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2050,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2051,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2052,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2053,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2054,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2055,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2056,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2057,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2058,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2059,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2060,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2061,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2062,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2063,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2064,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2065,2024-07-10 11:35:12.276509,CS_VT019,DS-vem-019-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2066,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2067,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2068,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2069,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2070,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2071,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2072,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2073,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2074,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2075,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2076,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2077,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2078,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2079,2024-07-10 11:35:12.276509,CS_VT021m1,DS-vem-21-MT1,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2080,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2081,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2082,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2083,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2084,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2085,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2086,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2087,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2088,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2089,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2090,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2091,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2092,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2093,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2094,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2095,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2096,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2097,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2098,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2099,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2100,2024-07-10 11:35:12.277506,CS_VT021m1,DS-vem-21-MT1,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2101,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2102,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2103,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2104,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2105,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2106,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2107,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2108,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2109,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2110,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2111,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2112,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2113,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2114,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2115,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2116,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2117,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2118,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2119,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2120,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2121,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2122,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2123,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2124,2024-07-10 11:35:12.280473,CS_VT021m1,DS-vem-21-MT1,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2125,2024-07-10 11:35:12.280473,CS_VT022,DS-vem-022-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2126,2024-07-10 11:35:12.280473,CS_VT022,DS-vem-022-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2127,2024-07-10 11:35:12.280473,CS_VT022,DS-vem-022-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2128,2024-07-10 11:35:12.280473,CS_VT022,DS-vem-022-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2129,2024-07-10 11:35:12.280473,CS_VT022,DS-vem-022-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2130,2024-07-10 11:35:12.280473,CS_VT022,DS-vem-022-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2131,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2132,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2133,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2134,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2135,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2136,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2137,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2138,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2139,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2140,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2141,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2142,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2143,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2144,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2145,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2146,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2147,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,BRAF,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2148,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,FLT1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2149,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2150,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2151,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2152,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2153,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2154,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2155,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2156,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2157,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2158,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2159,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2160,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2161,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2162,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2163,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2164,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2165,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2166,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2167,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2168,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2169,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2170,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2171,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2172,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2173,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2174,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2175,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2176,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2177,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2178,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2179,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2180,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2181,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2182,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2183,2024-07-10 11:35:12.281509,CS_VT022,DS-vem-022-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2184,2024-07-10 11:35:12.281509,CS_VT023,DS-vem-23-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2185,2024-07-10 11:35:12.281509,CS_VT023,DS-vem-23-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2186,2024-07-10 11:35:12.281509,CS_VT023,DS-vem-23-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2187,2024-07-10 11:35:12.281509,CS_VT023,DS-vem-23-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2188,2024-07-10 11:35:12.281509,CS_VT023,DS-vem-23-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2189,2024-07-10 11:35:12.281509,CS_VT023,DS-vem-23-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2190,2024-07-10 11:35:12.281509,CS_VT023,DS-vem-23-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2191,2024-07-10 11:35:12.281509,CS_VT023,DS-vem-23-T,MCL1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2192,2024-07-10 11:35:12.281509,CS_VT023,DS-vem-23-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2193,2024-07-10 11:35:12.282505,CS_VT023,DS-vem-23-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2194,2024-07-10 11:35:12.282505,CS_VT023,DS-vem-23-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2195,2024-07-10 11:35:12.282505,CS_VT023,DS-vem-23-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2196,2024-07-10 11:35:12.282505,CS_VT023,DS-vem-23-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2197,2024-07-10 11:35:12.282505,CS_VT023,DS-vem-23-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2198,2024-07-10 11:35:12.282505,CS_VT023,DS-vem-23-T,CHEK2,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2199,2024-07-10 11:35:12.282505,CS_VT023,DS-vem-23-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2200,2024-07-10 11:35:12.282505,CS_VT023,DS-vem-23-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2201,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2202,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2203,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2204,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2205,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2206,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2207,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2208,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,DAXX,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2209,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,MYC,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2210,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,NF2,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2211,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2212,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2213,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2214,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2215,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2216,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2217,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2218,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2219,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2220,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2221,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2222,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2223,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2224,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2225,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2226,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2227,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2228,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2229,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2230,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2231,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2232,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2233,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2234,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2235,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2236,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2237,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2238,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2239,2024-07-10 11:35:12.285525,CS_VT023,DS-vem-23-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2240,2024-07-10 11:35:12.286486,CS_VT023,DS-vem-23-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2241,2024-07-10 11:35:12.286486,CS_VT023,DS-vem-23-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2242,2024-07-10 11:35:12.286486,CS_VT023,DS-vem-23-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2243,2024-07-10 11:35:12.286486,CS_VT024,DS-vem-24-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2244,2024-07-10 11:35:12.286486,CS_VT024,DS-vem-24-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2245,2024-07-10 11:35:12.286486,CS_VT024,DS-vem-24-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2246,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2247,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2248,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2249,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2250,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2251,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2252,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2253,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2254,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2255,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2256,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2257,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2258,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2259,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2260,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2261,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2262,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2263,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2264,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2265,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2266,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2267,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2268,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2269,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2270,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,MITF,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2271,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2272,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2273,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2274,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2275,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2276,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2277,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2278,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2279,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2280,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2281,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2282,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2283,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2284,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2285,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2286,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2287,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2288,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2289,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2290,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2291,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2292,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2293,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2294,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2295,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2296,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2297,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2298,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2299,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2300,2024-07-10 11:35:12.286579,CS_VT024,DS-vem-24-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2301,2024-07-10 11:35:12.297459,CS_VT024,DS-vem-24-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2302,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2303,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2304,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2305,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2306,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2307,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2308,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2309,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2310,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2311,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2312,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2313,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2314,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2315,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2316,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2317,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2318,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2319,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2320,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2321,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2322,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2323,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2324,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2325,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2326,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2327,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2328,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2329,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2330,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2331,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2332,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2333,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2334,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2335,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2336,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2337,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2338,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2339,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2340,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2341,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2342,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2343,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2344,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2345,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2346,2024-07-10 11:35:12.297459,CS_VT026,DS-vem-26-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2347,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2348,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2349,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2350,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2351,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2352,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2353,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2354,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2355,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2356,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2357,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2358,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2359,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2360,2024-07-10 11:35:12.298457,CS_VT026,DS-vem-26-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2361,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2362,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2363,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2364,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2365,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2366,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2367,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2368,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2369,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2370,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2371,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2372,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2373,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2374,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2375,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2376,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2377,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2378,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2379,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2380,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2381,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2382,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2383,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2384,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2385,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2386,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2387,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2388,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2389,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2390,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2391,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2392,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2393,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2394,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2395,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2396,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2397,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2398,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2399,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2400,2024-07-10 11:35:12.298457,CS_VT027,DS-vem-27-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2401,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2402,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2403,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2404,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2405,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2406,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2407,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2408,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2409,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2410,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2411,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2412,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2413,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2414,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2415,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2416,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2417,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2418,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2419,2024-07-10 11:35:12.301458,CS_VT027,DS-vem-27-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2420,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2421,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2422,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2423,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2424,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2425,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2426,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2427,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2428,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2429,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2430,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2431,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2432,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2433,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2434,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2435,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2436,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2437,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2438,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2439,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2440,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2441,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2442,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2443,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2444,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2445,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2446,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2447,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2448,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2449,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2450,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2451,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2452,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2453,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2454,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2455,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2456,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2457,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2458,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2459,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2460,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2461,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2462,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2463,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2464,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2465,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2466,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2467,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2468,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2469,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2470,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2471,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2472,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2473,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2474,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2475,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2476,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2477,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2478,2024-07-10 11:35:12.301458,CS_VT006,DS-vem-006-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2479,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2480,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2481,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2482,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2483,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2484,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2485,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2486,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2487,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2488,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2489,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2490,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2491,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2492,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2493,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2494,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2495,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,MET,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2496,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,AKT2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2497,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,EZH2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2498,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,MLL3,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2499,2024-07-10 11:35:12.301458,CS_VT008T1,DS-vem-08-T1,GRM3,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2500,2024-07-10 11:35:12.304510,CS_VT008T1,DS-vem-08-T1,SMO,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2501,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2502,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2503,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2504,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2505,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2506,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2507,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2508,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2509,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2510,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2511,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2512,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2513,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2514,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2515,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2516,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2517,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2518,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2519,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2520,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2521,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2522,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2523,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2524,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2525,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2526,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2527,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2528,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2529,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2530,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2531,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2532,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2533,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2534,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2535,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2536,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2537,2024-07-10 11:35:12.307600,CS_VT008T1,DS-vem-08-T1,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2538,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2539,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2540,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2541,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2542,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2543,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2544,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2545,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2546,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2547,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2548,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2549,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2550,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2551,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2552,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2553,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2554,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2555,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2556,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2557,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2558,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2559,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2560,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2561,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2562,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,DAXX,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2563,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2564,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2565,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2566,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2567,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2568,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2569,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2570,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2571,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2572,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2573,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2574,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2575,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2576,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2577,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2578,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2579,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2580,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2581,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2582,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2583,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2584,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2585,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2586,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2587,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2588,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2589,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2590,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2591,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2592,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2593,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2594,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2595,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2596,2024-07-10 11:35:12.307600,CS_VT029,DS-vem-29-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2597,2024-07-10 11:35:12.307600,CS_VT030,DS-vem-30-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2598,2024-07-10 11:35:12.307600,CS_VT030,DS-vem-30-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2599,2024-07-10 11:35:12.307600,CS_VT030,DS-vem-30-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2600,2024-07-10 11:35:12.307600,CS_VT030,DS-vem-30-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2601,2024-07-10 11:35:12.312948,CS_VT030,DS-vem-30-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2602,2024-07-10 11:35:12.312948,CS_VT030,DS-vem-30-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2603,2024-07-10 11:35:12.312948,CS_VT030,DS-vem-30-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2604,2024-07-10 11:35:12.312948,CS_VT030,DS-vem-30-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2605,2024-07-10 11:35:12.312948,CS_VT030,DS-vem-30-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2606,2024-07-10 11:35:12.312948,CS_VT030,DS-vem-30-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2607,2024-07-10 11:35:12.312948,CS_VT030,DS-vem-30-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2608,2024-07-10 11:35:12.313355,CS_VT030,DS-vem-30-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2609,2024-07-10 11:35:12.313355,CS_VT030,DS-vem-30-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2610,2024-07-10 11:35:12.313355,CS_VT030,DS-vem-30-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2611,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2612,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2613,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2614,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2615,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2616,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2617,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2618,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2619,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2620,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2621,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2622,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2623,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2624,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2625,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2626,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2627,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2628,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,JAK2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2629,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2630,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2631,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2632,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2633,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2634,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2635,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2636,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2637,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2638,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2639,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2640,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2641,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2642,2024-07-10 11:35:12.313435,CS_VT030,DS-vem-30-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2643,2024-07-10 11:35:12.313934,CS_VT030,DS-vem-30-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2644,2024-07-10 11:35:12.313934,CS_VT030,DS-vem-30-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2645,2024-07-10 11:35:12.313934,CS_VT030,DS-vem-30-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2646,2024-07-10 11:35:12.313934,CS_VT030,DS-vem-30-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2647,2024-07-10 11:35:12.313934,CS_VT030,DS-vem-30-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2648,2024-07-10 11:35:12.313934,CS_VT030,DS-vem-30-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2649,2024-07-10 11:35:12.313934,CS_VT030,DS-vem-30-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2650,2024-07-10 11:35:12.313934,CS_VT030,DS-vem-30-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2651,2024-07-10 11:35:12.313934,CS_VT030,DS-vem-30-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2652,2024-07-10 11:35:12.313934,CS_VT030,DS-vem-30-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2653,2024-07-10 11:35:12.313934,CS_VT030,DS-vem-30-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2654,2024-07-10 11:35:12.313934,CS_VT030,DS-vem-30-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2655,2024-07-10 11:35:12.313934,CS_VT030,DS-vem-30-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2656,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2657,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2658,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2659,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2660,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2661,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2662,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2663,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2664,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2665,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2666,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,CDKN2A,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2667,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2668,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2669,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2670,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2671,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2672,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2673,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2674,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2675,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2676,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2677,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2678,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,BRAF,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2679,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2680,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2681,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2682,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2683,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2684,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,IGF1R,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2685,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,ETV1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2686,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,FAM46C,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2687,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2688,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2689,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2690,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2691,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2692,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2693,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2694,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2695,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2696,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2697,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2698,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2699,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2700,2024-07-10 11:35:12.313934,CS_VT009,DS-vem-09-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2701,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2702,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2703,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2704,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2705,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2706,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2707,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2708,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2709,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2710,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2711,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2712,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2713,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2714,2024-07-10 11:35:12.317671,CS_VT009,DS-vem-09-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2715,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2716,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2717,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2718,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2719,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2720,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2721,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2722,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2723,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2724,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2725,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2726,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2727,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2728,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2729,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2730,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2731,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2732,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2733,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2734,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2735,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2736,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2737,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2738,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2739,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2740,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2741,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2742,2024-07-10 11:35:12.317671,CS_VT005,DS-vem-05-T,MITF,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2743,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2744,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2745,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2746,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2747,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2748,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2749,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2750,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2751,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2752,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2753,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2754,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2755,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2756,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2757,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2758,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2759,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2760,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2761,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2762,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2763,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2764,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2765,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2766,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2767,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2768,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2769,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2770,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2771,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2772,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2773,2024-07-10 11:35:12.318669,CS_VT005,DS-vem-05-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2774,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2775,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,MDM2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2776,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2777,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2778,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2779,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2780,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2781,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2782,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2783,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,PTPRD,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2784,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,CDKN2A,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2785,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2786,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,TEK,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2787,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2788,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2789,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2790,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2791,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2792,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2793,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2794,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2795,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2796,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2797,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2798,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2799,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2800,2024-07-10 11:35:12.318669,CS_VT035,DS-vem-035-M,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2801,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2802,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2803,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2804,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2805,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,JAK2,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2806,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,HMGA2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2807,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,ERBB3,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2808,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,TBK1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2809,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,CDK4,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2810,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,PARK2,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2811,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,ROS1,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2812,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,PIK3C2G,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2813,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,EPHA7,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2814,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2815,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2816,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2817,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2818,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2819,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2820,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2821,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2822,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2823,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2824,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2825,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2826,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2827,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2828,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2829,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2830,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2831,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2832,2024-07-10 11:35:12.322670,CS_VT035,DS-vem-035-M,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2833,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2834,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2835,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2836,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2837,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2838,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2839,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2840,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,MCL1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2841,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2842,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,PTPRD,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2843,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2844,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2845,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2846,2024-07-10 11:35:12.322670,CS_VT036,DS-vem-036-P,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2847,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2848,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2849,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2850,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2851,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2852,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2853,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2854,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2855,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2856,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2857,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,DAXX,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2858,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,MYC,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2859,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2860,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2861,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2862,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,ETV1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2863,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2864,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,JAK2,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2865,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2866,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2867,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2868,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2869,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2870,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2871,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2872,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,EPHA7,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2873,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,RAC1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2874,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,PMS2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2875,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,GNAS,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2876,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,EPHB4,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2877,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,ABL2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2878,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2879,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2880,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2881,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2882,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2883,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2884,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2885,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2886,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2887,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2888,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2889,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2890,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2891,2024-07-10 11:35:12.323670,CS_VT036,DS-vem-036-P,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2892,2024-07-10 11:35:12.323670,CS_VT037,DS-vem-037-M,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2893,2024-07-10 11:35:12.323670,CS_VT037,DS-vem-037-M,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2894,2024-07-10 11:35:12.323670,CS_VT037,DS-vem-037-M,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2895,2024-07-10 11:35:12.323670,CS_VT037,DS-vem-037-M,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2896,2024-07-10 11:35:12.323670,CS_VT037,DS-vem-037-M,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2897,2024-07-10 11:35:12.323670,CS_VT037,DS-vem-037-M,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2898,2024-07-10 11:35:12.323670,CS_VT037,DS-vem-037-M,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2899,2024-07-10 11:35:12.323670,CS_VT037,DS-vem-037-M,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2900,2024-07-10 11:35:12.323670,CS_VT037,DS-vem-037-M,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2901,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2902,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2903,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2904,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2905,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2906,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2907,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2908,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2909,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2910,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2911,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2912,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2913,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2914,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2915,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2916,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2917,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2918,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2919,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2920,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2921,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2922,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2923,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2924,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2925,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2926,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2927,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2928,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2929,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2930,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2931,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2932,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2933,2024-07-10 11:35:12.327713,CS_VT037,DS-vem-037-M,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2934,2024-07-10 11:35:12.328713,CS_VT037,DS-vem-037-M,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2935,2024-07-10 11:35:12.328713,CS_VT037,DS-vem-037-M,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2936,2024-07-10 11:35:12.328713,CS_VT037,DS-vem-037-M,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2937,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2938,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2939,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2940,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2941,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2942,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2943,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2944,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2945,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2946,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2947,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2948,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2949,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2950,2024-07-10 11:35:12.328759,CS_VT037,DS-vem-037-M,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2951,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2952,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2953,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2954,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2955,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2956,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2957,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2958,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2959,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2960,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2961,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,CDKN2A,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2962,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2963,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2964,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2965,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2966,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2967,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2968,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2969,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2970,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2971,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2972,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2973,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2974,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2975,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2976,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,MYC,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2977,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2978,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2979,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2980,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2981,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2982,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2983,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2984,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2985,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2986,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2987,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2988,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2989,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2990,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,EPHA7,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2991,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2992,2024-07-10 11:35:12.328759,CS_VT038,DS-vem-038-M,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2993,2024-07-10 11:35:12.329680,CS_VT038,DS-vem-038-M,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2994,2024-07-10 11:35:12.329680,CS_VT038,DS-vem-038-M,EPHB4,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2995,2024-07-10 11:35:12.329680,CS_VT038,DS-vem-038-M,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2996,2024-07-10 11:35:12.329680,CS_VT038,DS-vem-038-M,CRKL,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2997,2024-07-10 11:35:12.329680,CS_VT038,DS-vem-038-M,MAPK1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2998,2024-07-10 11:35:12.329680,CS_VT038,DS-vem-038-M,SMARCB1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
2999,2024-07-10 11:35:12.329680,CS_VT038,DS-vem-038-M,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3000,2024-07-10 11:35:12.329680,CS_VT038,DS-vem-038-M,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3001,2024-07-10 11:35:12.333681,CS_VT038,DS-vem-038-M,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3002,2024-07-10 11:35:12.333681,CS_VT038,DS-vem-038-M,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3003,2024-07-10 11:35:12.333681,CS_VT038,DS-vem-038-M,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3004,2024-07-10 11:35:12.333681,CS_VT038,DS-vem-038-M,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3005,2024-07-10 11:35:12.333681,CS_VT038,DS-vem-038-M,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3006,2024-07-10 11:35:12.333681,CS_VT038,DS-vem-038-M,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3007,2024-07-10 11:35:12.333681,CS_VT038,DS-vem-038-M,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3008,2024-07-10 11:35:12.333681,CS_VT038,DS-vem-038-M,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3009,2024-07-10 11:35:12.333681,CS_VT038,DS-vem-038-M,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3010,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3011,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,MDM2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3012,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3013,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3014,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3015,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3016,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3017,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3018,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3019,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3020,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3021,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3022,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3023,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3024,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3025,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3026,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3027,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3028,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3029,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3030,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3031,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3032,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3033,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3034,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3035,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3036,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3037,2024-07-10 11:35:12.333681,CS_VT040,DS-vem-040-M,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3038,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3039,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3040,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3041,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3042,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3043,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3044,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3045,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3046,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3047,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3048,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3049,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3050,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3051,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3052,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3053,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3054,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3055,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3056,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3057,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3058,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3059,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3060,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3061,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3062,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3063,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3064,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3065,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3066,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3067,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3068,2024-07-10 11:35:12.334679,CS_VT040,DS-vem-040-M,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3069,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3070,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3071,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3072,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3073,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3074,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3075,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3076,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3077,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3078,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3079,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,CDKN2A,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3080,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3081,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3082,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3083,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3084,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3085,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3086,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3087,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3088,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3089,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3090,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3091,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3092,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3093,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3094,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3095,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3096,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3097,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3098,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3099,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3100,2024-07-10 11:35:12.334679,CS_VT041,DS-vem-041-M,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3101,2024-07-10 11:35:12.337820,CS_VT041,DS-vem-041-M,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3102,2024-07-10 11:35:12.337820,CS_VT041,DS-vem-041-M,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3103,2024-07-10 11:35:12.337820,CS_VT041,DS-vem-041-M,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3104,2024-07-10 11:35:12.337820,CS_VT041,DS-vem-041-M,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3105,2024-07-10 11:35:12.337820,CS_VT041,DS-vem-041-M,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3106,2024-07-10 11:35:12.337820,CS_VT041,DS-vem-041-M,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3107,2024-07-10 11:35:12.337820,CS_VT041,DS-vem-041-M,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3108,2024-07-10 11:35:12.337820,CS_VT041,DS-vem-041-M,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3109,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3110,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3111,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3112,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3113,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3114,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3115,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3116,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3117,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3118,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3119,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3120,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3121,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3122,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3123,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3124,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3125,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3126,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3127,2024-07-10 11:35:12.338820,CS_VT041,DS-vem-041-M,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3128,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3129,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3130,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3131,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3132,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3133,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,CDKN2B,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3134,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3135,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3136,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3137,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3138,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3139,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3140,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,TEK,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3141,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3142,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3143,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3144,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3145,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3146,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3147,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3148,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3149,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3150,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3151,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3152,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3153,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,MYC,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3154,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3155,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3156,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3157,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3158,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3159,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3160,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3161,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3162,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3163,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3164,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3165,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3166,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3167,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3168,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3169,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3170,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3171,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3172,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3173,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3174,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3175,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3176,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3177,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,NBN,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3178,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3179,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3180,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3181,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3182,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3183,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3184,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3185,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3186,2024-07-10 11:35:12.338820,CS_VT043,DS-vem-043-M,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3187,2024-07-10 11:35:12.338820,CS_VT045,DS-vem-045-M,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3188,2024-07-10 11:35:12.338820,CS_VT045,DS-vem-045-M,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3189,2024-07-10 11:35:12.339820,CS_VT045,DS-vem-045-M,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3190,2024-07-10 11:35:12.339820,CS_VT045,DS-vem-045-M,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3191,2024-07-10 11:35:12.339820,CS_VT045,DS-vem-045-M,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3192,2024-07-10 11:35:12.339820,CS_VT045,DS-vem-045-M,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3193,2024-07-10 11:35:12.339820,CS_VT045,DS-vem-045-M,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3194,2024-07-10 11:35:12.339820,CS_VT045,DS-vem-045-M,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3195,2024-07-10 11:35:12.339820,CS_VT045,DS-vem-045-M,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3196,2024-07-10 11:35:12.339820,CS_VT045,DS-vem-045-M,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3197,2024-07-10 11:35:12.339820,CS_VT045,DS-vem-045-M,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3198,2024-07-10 11:35:12.339820,CS_VT045,DS-vem-045-M,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3199,2024-07-10 11:35:12.339820,CS_VT045,DS-vem-045-M,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3200,2024-07-10 11:35:12.339820,CS_VT045,DS-vem-045-M,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3201,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3202,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3203,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3204,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3205,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3206,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3207,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3208,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3209,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3210,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3211,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3212,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3213,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3214,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3215,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3216,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3217,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3218,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3219,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3220,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3221,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3222,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3223,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3224,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3225,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3226,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3227,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3228,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3229,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3230,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3231,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3232,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3233,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3234,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3235,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3236,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3237,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3238,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3239,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3240,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3241,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3242,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3243,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3244,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3245,2024-07-10 11:35:12.342820,CS_VT045,DS-vem-045-M,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3246,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3247,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3248,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3249,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3250,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3251,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3252,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3253,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3254,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3255,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3256,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3257,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3258,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3259,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3260,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3261,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3262,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3263,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3264,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3265,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3266,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3267,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3268,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3269,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3270,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3271,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3272,2024-07-10 11:35:12.342820,CS_VT049,DS-vem-049-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3273,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3274,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3275,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3276,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3277,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3278,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3279,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3280,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3281,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3282,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3283,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3284,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3285,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3286,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3287,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,PMS2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3288,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3289,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3290,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3291,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3292,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3293,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3294,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3295,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3296,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3297,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3298,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3299,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3300,2024-07-10 11:35:12.343820,CS_VT049,DS-vem-049-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3301,2024-07-10 11:35:12.346619,CS_VT049,DS-vem-049-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3302,2024-07-10 11:35:12.346619,CS_VT049,DS-vem-049-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3303,2024-07-10 11:35:12.346619,CS_VT049,DS-vem-049-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3304,2024-07-10 11:35:12.346619,CS_VT049,DS-vem-049-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3305,2024-07-10 11:35:12.346619,CS_VT050,DS-vem-050-M,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3306,2024-07-10 11:35:12.346619,CS_VT050,DS-vem-050-M,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3307,2024-07-10 11:35:12.346619,CS_VT050,DS-vem-050-M,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3308,2024-07-10 11:35:12.346619,CS_VT050,DS-vem-050-M,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3309,2024-07-10 11:35:12.346619,CS_VT050,DS-vem-050-M,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3310,2024-07-10 11:35:12.346619,CS_VT050,DS-vem-050-M,CDKN2B,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3311,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,CDKN2C,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3312,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3313,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3314,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3315,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,CDKN2A,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3316,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3317,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3318,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3319,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3320,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3321,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3322,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3323,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3324,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3325,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3326,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3327,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3328,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3329,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3330,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,MYC,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3331,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3332,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3333,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3334,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3335,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3336,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3337,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3338,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3339,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3340,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3341,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3342,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3343,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3344,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3345,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3346,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3347,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3348,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3349,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3350,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3351,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3352,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3353,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3354,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3355,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,IRF4,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3356,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3357,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3358,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3359,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3360,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3361,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3362,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3363,2024-07-10 11:35:12.347637,CS_VT050,DS-vem-050-M,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3364,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3365,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3366,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3367,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3368,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3369,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3370,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3371,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,MCL1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3372,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3373,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3374,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3375,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3376,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3377,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3378,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3379,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3380,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3381,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3382,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3383,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3384,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3385,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3386,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3387,2024-07-10 11:35:12.347637,CS_VT051,DS-vem-051-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3388,2024-07-10 11:35:12.348636,CS_VT051,DS-vem-051-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3389,2024-07-10 11:35:12.348636,CS_VT051,DS-vem-051-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3390,2024-07-10 11:35:12.348636,CS_VT051,DS-vem-051-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3391,2024-07-10 11:35:12.348636,CS_VT051,DS-vem-051-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3392,2024-07-10 11:35:12.348636,CS_VT051,DS-vem-051-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3393,2024-07-10 11:35:12.348636,CS_VT051,DS-vem-051-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3394,2024-07-10 11:35:12.348636,CS_VT051,DS-vem-051-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3395,2024-07-10 11:35:12.348636,CS_VT051,DS-vem-051-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3396,2024-07-10 11:35:12.348636,CS_VT051,DS-vem-051-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3397,2024-07-10 11:35:12.348636,CS_VT051,DS-vem-051-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3398,2024-07-10 11:35:12.348636,CS_VT051,DS-vem-051-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3399,2024-07-10 11:35:12.348636,CS_VT051,DS-vem-051-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3400,2024-07-10 11:35:12.348636,CS_VT051,DS-vem-051-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3401,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3402,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3403,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3404,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3405,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3406,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3407,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3408,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3409,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3410,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3411,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3412,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3413,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3414,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3415,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,CDC73,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3416,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3417,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3418,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3419,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3420,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3421,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3422,2024-07-10 11:35:12.351644,CS_VT051,DS-vem-051-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3423,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3424,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3425,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3426,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3427,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3428,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3429,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3430,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3431,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3432,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3433,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3434,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3435,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3436,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3437,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3438,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3439,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3440,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3441,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3442,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3443,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3444,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3445,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3446,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3447,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,DAXX,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3448,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3449,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3450,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3451,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3452,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3453,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3454,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3455,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3456,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3457,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3458,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3459,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3460,2024-07-10 11:35:12.351644,CS_VT053,DS-vem-053-M,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3461,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3462,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3463,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3464,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3465,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3466,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3467,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3468,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3469,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3470,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3471,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3472,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3473,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3474,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3475,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3476,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3477,2024-07-10 11:35:12.352639,CS_VT053,DS-vem-053-M,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3478,2024-07-10 11:35:12.352839,CS_VT053,DS-vem-053-M,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3479,2024-07-10 11:35:12.352839,CS_VT053,DS-vem-053-M,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3480,2024-07-10 11:35:12.352839,CS_VT053,DS-vem-053-M,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3481,2024-07-10 11:35:12.352839,CS_VT053,DS-vem-053-M,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3482,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3483,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3484,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3485,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3486,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3487,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3488,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3489,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3490,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3491,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3492,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3493,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3494,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3495,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3496,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3497,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3498,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3499,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3500,2024-07-10 11:35:12.352839,CS_VT054,DS-vem-054-M,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3501,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3502,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3503,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3504,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3505,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3506,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3507,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3508,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3509,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3510,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3511,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3512,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3513,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3514,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3515,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3516,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3517,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3518,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3519,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3520,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3521,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3522,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3523,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3524,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3525,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3526,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3527,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3528,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3529,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3530,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3531,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3532,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3533,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3534,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3535,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3536,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3537,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3538,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3539,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3540,2024-07-10 11:35:12.356037,CS_VT054,DS-vem-054-M,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3541,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3542,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3543,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3544,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3545,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,PTEN,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3546,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,CDKN2B,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3547,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3548,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3549,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,FGFR2,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3550,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,PTPRD,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3551,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,CDKN2A,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3552,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3553,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3554,2024-07-10 11:35:12.356037,CS_VT056,DS-vem-056-M,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3555,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3556,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3557,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3558,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3559,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3560,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3561,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3562,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3563,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3564,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3565,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3566,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3567,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3568,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3569,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3570,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3571,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3572,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,JAK2,-2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3573,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3574,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3575,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3576,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3577,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3578,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3579,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3580,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3581,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3582,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3583,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3584,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3585,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3586,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3587,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3588,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3589,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3590,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3591,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3592,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3593,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3594,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3595,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3596,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3597,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3598,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3599,2024-07-10 11:35:12.357036,CS_VT056,DS-vem-056-M,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3600,2024-07-10 11:35:12.357036,CS_VT057,DS-vem-057-M,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3601,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3602,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3603,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3604,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3605,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3606,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3607,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3608,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3609,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3610,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3611,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3612,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3613,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3614,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3615,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3616,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3617,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3618,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3619,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3620,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3621,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3622,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3623,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3624,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3625,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3626,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3627,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3628,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3629,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,ETV1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3630,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3631,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3632,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3633,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3634,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3635,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3636,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3637,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3638,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3639,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3640,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,RAC1,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3641,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,PMS2,2,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3642,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3643,2024-07-10 11:35:12.360142,CS_VT057,DS-vem-057-M,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3644,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3645,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3646,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3647,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3648,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3649,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3650,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3651,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3652,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3653,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3654,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3655,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3656,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3657,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3658,2024-07-10 11:35:12.361068,CS_VT057,DS-vem-057-M,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3659,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3660,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3661,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3662,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3663,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3664,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3665,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3666,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3667,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3668,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3669,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3670,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3671,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3672,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3673,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3674,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3675,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3676,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3677,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3678,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3679,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3680,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3681,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3682,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3683,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3684,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3685,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3686,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3687,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3688,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3689,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3690,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3691,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3692,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3693,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3694,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3695,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3696,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3697,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3698,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3699,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3700,2024-07-10 11:35:12.361068,CS_VT058,DS-vem-058-M,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3701,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3702,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3703,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3704,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3705,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3706,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3707,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3708,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3709,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3710,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3711,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3712,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3713,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3714,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3715,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3716,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3717,2024-07-10 11:35:12.364336,CS_VT058,DS-vem-058-M,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3718,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3719,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3720,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3721,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3722,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3723,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3724,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3725,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3726,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3727,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3728,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3729,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3730,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3731,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3732,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3733,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3734,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3735,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3736,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3737,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3738,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3739,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3740,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3741,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3742,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3743,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3744,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3745,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3746,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3747,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3748,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3749,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3750,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3751,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3752,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3753,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3754,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3755,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3756,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3757,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3758,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3759,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3760,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3761,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3762,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3763,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3764,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3765,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3766,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3767,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3768,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3769,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3770,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3771,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3772,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3773,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3774,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3775,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3776,2024-07-10 11:35:12.364336,CS_MT004,DS-mek-004-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3777,2024-07-10 11:35:12.364336,CS_MT08m1,DS-mek-008-M1,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3778,2024-07-10 11:35:12.364336,CS_MT08m1,DS-mek-008-M1,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3779,2024-07-10 11:35:12.364336,CS_MT08m1,DS-mek-008-M1,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3780,2024-07-10 11:35:12.364336,CS_MT08m1,DS-mek-008-M1,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3781,2024-07-10 11:35:12.364336,CS_MT08m1,DS-mek-008-M1,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3782,2024-07-10 11:35:12.365383,CS_MT08m1,DS-mek-008-M1,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3783,2024-07-10 11:35:12.365383,CS_MT08m1,DS-mek-008-M1,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3784,2024-07-10 11:35:12.365383,CS_MT08m1,DS-mek-008-M1,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3785,2024-07-10 11:35:12.365383,CS_MT08m1,DS-mek-008-M1,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3786,2024-07-10 11:35:12.365383,CS_MT08m1,DS-mek-008-M1,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3787,2024-07-10 11:35:12.365383,CS_MT08m1,DS-mek-008-M1,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3788,2024-07-10 11:35:12.365383,CS_MT08m1,DS-mek-008-M1,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3789,2024-07-10 11:35:12.365383,CS_MT08m1,DS-mek-008-M1,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3790,2024-07-10 11:35:12.365383,CS_MT08m1,DS-mek-008-M1,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3791,2024-07-10 11:35:12.365503,CS_MT08m1,DS-mek-008-M1,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3792,2024-07-10 11:35:12.365503,CS_MT08m1,DS-mek-008-M1,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3793,2024-07-10 11:35:12.365503,CS_MT08m1,DS-mek-008-M1,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3794,2024-07-10 11:35:12.365503,CS_MT08m1,DS-mek-008-M1,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3795,2024-07-10 11:35:12.365503,CS_MT08m1,DS-mek-008-M1,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3796,2024-07-10 11:35:12.365503,CS_MT08m1,DS-mek-008-M1,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3797,2024-07-10 11:35:12.365503,CS_MT08m1,DS-mek-008-M1,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3798,2024-07-10 11:35:12.365503,CS_MT08m1,DS-mek-008-M1,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3799,2024-07-10 11:35:12.365503,CS_MT08m1,DS-mek-008-M1,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3800,2024-07-10 11:35:12.365503,CS_MT08m1,DS-mek-008-M1,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3801,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3802,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3803,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3804,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3805,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3806,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3807,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3808,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3809,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3810,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3811,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3812,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3813,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3814,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3815,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3816,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3817,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3818,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3819,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3820,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3821,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3822,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3823,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3824,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3825,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3826,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3827,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3828,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3829,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3830,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3831,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3832,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3833,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3834,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3835,2024-07-10 11:35:12.366537,CS_MT08m1,DS-mek-008-M1,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3836,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,PIK3CB,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3837,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,MDM2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3838,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,FOXL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3839,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,PIK3CA,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3840,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,PTEN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3841,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,CDKN2B,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3842,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,CDKN2C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3843,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,MCL1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3844,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,FGFR2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3845,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,PTPRD,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3846,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,CDKN2A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3847,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,FAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3848,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,TEK,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3849,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,MAP3K8,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3850,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,CHEK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3851,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,TET1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3852,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,MET,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3853,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,AKT2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3854,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,EZH2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3855,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,MLL3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3856,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,GRM3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3857,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,SMO,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3858,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,BRAF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3859,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,FLT1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3860,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,DAXX,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3861,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,MYC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3862,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,NF2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3863,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,MITF,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3864,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,IGF1R,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3865,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,ETV1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3866,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,FAM46C,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3867,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,JAK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3868,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,HMGA2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3869,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,ERBB3,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3870,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,TBK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3871,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,CDK4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3872,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,PARK2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3873,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,ROS1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3874,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,PIK3C2G,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3875,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,EPHA7,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3876,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,RAC1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3877,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,PMS2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3878,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,GNAS,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3879,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,EPHB4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3880,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,ABL2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3881,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,CRKL,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3882,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,MAPK1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3883,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,SMARCB1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3884,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,KLF6,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3885,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,NBN,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3886,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,IRF4,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3887,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,CDC73,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3888,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,INSR,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3889,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,FH,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3890,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,PRKAR1A,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3891,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,CCND1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3892,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,SHQ1,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3893,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,CDC42EP2,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"
3894,2024-07-10 11:35:12.366537,CS_VT061,DS-vem-061-T,APC,0,pre treatment,"{'title': 'PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma', 'author': 'Federica Catalanotti, David B. Solit', 'journal': 'JCO Precision Oncology', 'location': 'New York (United States)', 'date': 2017}"